综合性多omics QTL定位地图监管架构在老化的人类大脑的结构
medRxiv : the preprint server for health sciences
|May 19, 2025
概括
新的多任务学习方法ColocBoost有效地整合了大规模的多omics数据用于遗传研究. 它识别了许多特征的共同遗传信号,改善了对阿尔茨海默病等复杂疾病的洞察力.
科学领域:
- 基因组学就是基因组学.
- 计算生物学 计算生物学
- 统计遗传学 统计遗传学
背景情况:
- 多特征QTL (xQTL) 协同定位识别了分子数据和疾病中共享的遗传病因.
- 整合大规模的多omics数据用于xQTL监管洞察力受到当前方法的可扩展性和效率的限制.
研究的目的:
- 开发一种可扩展和高效的多任务学习方法,ColocBoost,用于多特征的QTL定位化.
- 通过计算多个因果变异和适应性合特征,增强共享遗传信号和因果变异的检测.
主要方法:
- ColocBoost 使用一个专门的梯度增强框架来实现多任务学习.
- 该方法在全基因组范围内应用于来自老化大脑皮层 (ROSMAP) 的17个基因级xQTL数据集,涵盖多种细胞类型,大脑区域和分子模式 (表达,拼接,蛋白质丰富性).
主要成果:
- ColocBoost 确定了 16,503 个不同的 colocalization 事件,显示了 57 个复杂疾病/特征的遗传性增强了 10.7 倍.
- 它与CRISPR验证的元素基因对表现出强烈的一致性,并确定了阿尔茨海默病 (AD) 局部化位置的2.5倍,解释了AD遗传率的两倍.
- 该方法增强了基因远距离局部化的检测,与已知的增强剂-基因链接保持一致,并为AD病变发生过程中BLNK和CTSH等基因提供功能支持.
结论:
- ColocBoost 提供了一个可扩展和高效的方法,用于多特征的 QTL 定位化,促进了多omics 数据的集成.
- 该方法显著改善了共享遗传信号和因果变异的识别,特别是在像AD这样的复杂疾病中.
- ColocBoost提供了对疾病易感点和潜在的监管机制的新功能洞察力.
更多相关视频
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


